Feasibility Open Label Study Evaluating the Use of Process-Instructed Self Neuro-Modulation (PRISM) for Attention Deficit/Hyperactivity Disorder(ADHD)

Brief description of study

This is a single-arm, open-label feasibility study. A maximum of 15 participants will be enrolled. All participants will undergo a novel neurofeedback intervention, targeting down-regulation of deep limbic structures, specifically the amygdalae. Participants will complete 15 neurofeedback sessions delivered twice weekly over 8 consecutive weeks. The intervention will be delivered via the PRISM platform.


Clinical Study Identifier: s20-01086
ClinicalTrials.gov Identifier: NCT04640766
Principal Investigator: Lenard A Adler.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.